Companies / BOC Sciences / Bavituximab
BOC Sciences

Bavituximab | BOC Sciences

Bavituximab is a chimeric monoclonal antibody that targets phosphatidylserine by binding to the phosphatidylserine-binding protein _2-glycoprotein 1 (_2GP1). Bavituximab has the potential for the treatment of cancers and viral infection.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.